Loading patent…
AssigneeRegeneron Pharmaceuticals, Inc.
InventorsTong Zhang, Erica Pyles, Michael Rosconi, Nina Liu, Supriya Patel, Eric Smith, Andrew Murphy, Chiayang Lin, Samuel Davis
Estimating the term…
Antigen binding molecules (ABMs) comprising Fab domains in non-native configurations, ABM conjugates comprising the ABMs and cytotoxic or cytostatic agents, pharmaceutical compositions containing the ABMs and ABM conjugates, methods of using the ABMs, ABM conjugates and pharmaceutical compositions for treating cancer, nucleic acids encoding the ABMs, cells engineered to express the ABMs, and methods of producing ABMs.
A method, comprising contacting a target molecule having a molecular weight of less than 100 kDa exclusive of post-translational modifications with an antigen-binding molecule comprising:
Dependencies are inferred from the claim text.